Emergence of Parechovirus A3 as the Leading Cause of Central Nervous System Infection, Surpassing Any Single Enterovirus Type, in Children in Kansas City, Missouri, USA, from 2007 to 2016

Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) col...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical microbiology Vol. 59; no. 6
Main Authors Sasidharan, Anjana, Banerjee, Dithi, Harrison, Christopher J., Selvarangan, Rangaraj
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 19.05.2021
Subjects
Epidemiology
epidemiology
infants
central nervous system infections
enterovirus
children
parechovirus
Online AccessGet full text

Cover

Abstract Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children’s Mercy-Kansas City (CMKC) from 2007 through 2016. Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children’s Mercy-Kansas City (CMKC) from 2007 through 2016. The overall prevalence for EV was 16% (862/5,362) and 7% (271/4,016) for PeV. Among all picornavirus CSF detections, EV was 76%, and PeV-A was 24%. Multiple EV types cocirculated each year, with a total of 31 EV types detected in the 10-year period; the majority belonged to EV-B species (96%). Two PeV-A types were detected; PeV-A3 was the dominant PeV-A type (95%). The top five picornaviruses (PeV-A3, 26%; E30, 11%; E6, 10%; E18, 9%; E9, 7%) in the CSF of infants accounted for two-thirds of all detections, and PeV-A3 was the leading picornavirus detected. Routine testing and reporting of PeV-A in addition to EV, especially in children under 6 months old with acute febrile illnesses, could reduce hospital stays and antibiotic usage.
AbstractList Picornaviruses, including species A to D (EV) and species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children's Mercy-Kansas City (CMKC) from 2007 through 2016. The overall prevalence for EV was 16% (862/5,362) and 7% (271/4,016) for PeV. Among all picornavirus CSF detections, EV was 76%, and PeV-A was 24%. Multiple EV types cocirculated each year, with a total of 31 EV types detected in the 10-year period; the majority belonged to EV-B species (96%). Two PeV-A types were detected; PeV-A3 was the dominant PeV-A type (95%). The top five picornaviruses (PeV-A3, 26%; E30, 11%; E6, 10%; E18, 9%; E9, 7%) in the CSF of infants accounted for two-thirds of all detections, and PeV-A3 was the leading picornavirus detected. Routine testing and reporting of PeV-A in addition to EV, especially in children under 6 months old with acute febrile illnesses, could reduce hospital stays and antibiotic usage.
Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children’s Mercy-Kansas City (CMKC) from 2007 through 2016. The overall prevalence for EV was 16% (862/5,362) and 7% (271/4,016) for PeV. Among all picornavirus CSF detections, EV was 76%, and PeV-A was 24%. Multiple EV types cocirculated each year, with a total of 31 EV types detected in the 10-year period; the majority belonged to EV-B species (96%). Two PeV-A types were detected; PeV-A3 was the dominant PeV-A type (95%). The top five picornaviruses (PeV-A3, 26%; E30, 11%; E6, 10%; E18, 9%; E9, 7%) in the CSF of infants accounted for two-thirds of all detections, and PeV-A3 was the leading picornavirus detected. Routine testing and reporting of PeV-A in addition to EV, especially in children under 6 months old with acute febrile illnesses, could reduce hospital stays and antibiotic usage.
Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children’s Mercy-Kansas City (CMKC) from 2007 through 2016. Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children’s Mercy-Kansas City (CMKC) from 2007 through 2016. The overall prevalence for EV was 16% (862/5,362) and 7% (271/4,016) for PeV. Among all picornavirus CSF detections, EV was 76%, and PeV-A was 24%. Multiple EV types cocirculated each year, with a total of 31 EV types detected in the 10-year period; the majority belonged to EV-B species (96%). Two PeV-A types were detected; PeV-A3 was the dominant PeV-A type (95%). The top five picornaviruses (PeV-A3, 26%; E30, 11%; E6, 10%; E18, 9%; E9, 7%) in the CSF of infants accounted for two-thirds of all detections, and PeV-A3 was the leading picornavirus detected. Routine testing and reporting of PeV-A in addition to EV, especially in children under 6 months old with acute febrile illnesses, could reduce hospital stays and antibiotic usage.
Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children’s Mercy-Kansas City (CMKC) from 2007 through 2016. The overall prevalence for EV was 16% (862/5,362) and 7% (271/4,016) for PeV. Among all picornavirus CSF detections, EV was 76%, and PeV-A was 24%. Multiple EV types cocirculated each year, with a total of 31 EV types detected in the 10-year period; the majority belonged to EV-B species (96%). Two PeV-A types were detected; PeV-A3 was the dominant PeV-A type (95%). The top five picornaviruses (PeV-A3, 26%; E30, 11%; E6, 10%; E18, 9%; E9, 7%) in the CSF of infants accounted for two-thirds of all detections, and PeV-A3 was the leading picornavirus detected. Routine testing and reporting of PeV-A in addition to EV, especially in children under 6 months old with acute febrile illnesses, could reduce hospital stays and antibiotic usage.
Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children's Mercy-Kansas City (CMKC) from 2007 through 2016. The overall prevalence for EV was 16% (862/5,362) and 7% (271/4,016) for PeV. Among all picornavirus CSF detections, EV was 76%, and PeV-A was 24%. Multiple EV types cocirculated each year, with a total of 31 EV types detected in the 10-year period; the majority belonged to EV-B species (96%). Two PeV-A types were detected; PeV-A3 was the dominant PeV-A type (95%). The top five picornaviruses (PeV-A3, 26%; E30, 11%; E6, 10%; E18, 9%; E9, 7%) in the CSF of infants accounted for two-thirds of all detections, and PeV-A3 was the leading picornavirus detected. Routine testing and reporting of PeV-A in addition to EV, especially in children under 6 months old with acute febrile illnesses, could reduce hospital stays and antibiotic usage.Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the United States. We investigated the molecular epidemiology of EV and PeV-A over 10 years in cerebrospinal fluid (CSF) collected from children seen at Children's Mercy-Kansas City (CMKC) from 2007 through 2016. The overall prevalence for EV was 16% (862/5,362) and 7% (271/4,016) for PeV. Among all picornavirus CSF detections, EV was 76%, and PeV-A was 24%. Multiple EV types cocirculated each year, with a total of 31 EV types detected in the 10-year period; the majority belonged to EV-B species (96%). Two PeV-A types were detected; PeV-A3 was the dominant PeV-A type (95%). The top five picornaviruses (PeV-A3, 26%; E30, 11%; E6, 10%; E18, 9%; E9, 7%) in the CSF of infants accounted for two-thirds of all detections, and PeV-A3 was the leading picornavirus detected. Routine testing and reporting of PeV-A in addition to EV, especially in children under 6 months old with acute febrile illnesses, could reduce hospital stays and antibiotic usage.
Author Sasidharan, Anjana
Harrison, Christopher J.
Selvarangan, Rangaraj
Banerjee, Dithi
Author_xml – sequence: 1
  givenname: Anjana
  surname: Sasidharan
  fullname: Sasidharan, Anjana
  organization: Department of Pathology and Laboratory Medicine, Children’s Mercy Hospital and Clinics, Kansas City, Missouri, USA
– sequence: 2
  givenname: Dithi
  surname: Banerjee
  fullname: Banerjee, Dithi
  organization: Department of Pathology and Laboratory Medicine, Children’s Mercy Hospital and Clinics, Kansas City, Missouri, USA
– sequence: 3
  givenname: Christopher J.
  surname: Harrison
  fullname: Harrison, Christopher J.
  organization: Division of Infectious Diseases, Children’s Mercy Hospital and Clinics, Kansas City, Missouri, USA
– sequence: 4
  givenname: Rangaraj
  orcidid: 0000-0003-3275-6657
  surname: Selvarangan
  fullname: Selvarangan, Rangaraj
  organization: Department of Pathology and Laboratory Medicine, Children’s Mercy Hospital and Clinics, Kansas City, Missouri, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33692140$$D View this record in MEDLINE/PubMed
BookMark eNp1kU2P0zAQhi20iP2AG2fkI0jJMv5ImlyQqqjAQheQWiRulptMWq8Su9hJpf42_hzutqwAwWlG8jOv5533kpxZZ5GQ5wyuGePF6w_V7TXwUmQph0fkgkFZpHkO387IBUCZpYyJyTm5DOEOgEmZZU_IuRB5yZmEC_Jj1qNfo62RupZ-0R7rjdsZPwY6FVQHOmyQzlE3xq5ppcdwz1VoB687-gn9zkV0sQ8D9vTGtlgPxtmELka_1SEcpqZ2Txex6ZDO7ID-JL_cbzGhxtJqY7rGoz30H7UN8dPKDPuE3poQ3OhNQr8upgltvespB5jQwcXK8qfkcau7gM9O9Yos386W1ft0_vndTTWdp1oWckgztpo0TSkRNZQT2cIKRL3SDaLIUBZlk6OUjQAoWFkz3kKBjLV5q9sCVroUV-TNUXY7rnps6qN3tfWm136vnDbqzxdrNmrtdqoQLIcSosDLk4B330cMg-pNqLHrtMV4PcUzAFHwjMmIvjqiOvRc3UX3NjpTDNQhaxWzVvdZK36QffH7Xg8L_Qo3AskRqL0LwWP7gPxHj_-F12bQhzijK9P9e-gnko7FyQ
CitedBy_id crossref_primary_10_1093_jpids_piae069
crossref_primary_10_3389_fimmu_2021_753683
crossref_primary_10_3390_v14071499
crossref_primary_10_1007_s40588_023_00197_3
crossref_primary_10_1186_s13052_023_01550_4
crossref_primary_10_3390_microorganisms13010111
crossref_primary_10_1016_j_pediatrneurol_2022_02_005
crossref_primary_10_1128_jcm_01139_23
crossref_primary_10_1016_j_jcv_2021_104939
crossref_primary_10_1093_infdis_jiac213
crossref_primary_10_1038_s41467_024_47825_0
crossref_primary_10_3389_fped_2021_719119
Cites_doi 10.1016/j.jcv.2010.04.007
10.1128/JCM.01698-18
10.1128/JCM.00542-06
10.1086/498905
10.1016/j.jiac.2017.04.009
10.2807/1560-7917.es2014.19.46.20964
10.1111/ped.13467
10.1097/INF.0b013e318194596a
10.1002/jmv.21374
10.1097/INF.0000000000000401
10.1097/INF.0000000000001718
10.1128/JCM.02106-20
10.1002/jmv.22023
10.1097/INF.0b013e3181a7ab5f
10.1186/s12985-015-0427-9
10.1097/INF.0000000000000112
10.1128/JCM.00168-08
10.1016/j.jcv.2011.07.008
10.1097/INF.0b013e318276b328
10.7883/yoken1952.45.151
10.1128/JCM.01982-12
10.1097/INF.0b013e3181fbefc8
10.1016/j.jcv.2013.05.023
10.1086/599094
10.1093/jpids/pix010
10.3345/kjp.2015.58.3.102
10.15585/mmwr.mm6434a3
10.15585/mmwr.mm6718a2
10.1002/jmv.21006
10.1097/INF.0b013e31815c1b07
10.1007/s00431-016-2725-7
10.1542/peds.2012-3077
ContentType Journal Article
Copyright Copyright © 2021 American Society for Microbiology.
Copyright © 2021 American Society for Microbiology. 2021 American Society for Microbiology
Copyright_xml – notice: Copyright © 2021 American Society for Microbiology.
– notice: Copyright © 2021 American Society for Microbiology. 2021 American Society for Microbiology
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1128/JCM.02935-20
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-660X
Editor Diekema, Daniel J
Editor_xml – sequence: 1
  givenname: Daniel J
  surname: Diekema
  fullname: Diekema, Daniel J
ExternalDocumentID PMC8316090
02935-20
33692140
10_1128_JCM_02935_20
Genre Journal Article
GroupedDBID ---
.55
0R~
18M
29K
2WC
39C
4.4
53G
5GY
5RE
5VS
AAGFI
AAYXX
ABOCM
ABPPZ
ACGFO
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
F5P
FRP
GX1
H13
HYE
HZ~
KQ8
L7B
O9-
OK1
P2P
P6G
RHI
RNS
RPM
RSF
TR2
W8F
WOQ
X7M
ZCA
~KM
NPM
RHF
UCJ
YIF
-
0R
55
ABFLS
ADACO
BXI
HZ
KM
ZA5
7X8
5PM
ID FETCH-LOGICAL-a484t-51b7dd94eea0974f0b03cbadee35e489d6e44d300819c12f08e11f6faf80ba93
ISSN 0095-1137
1098-660X
IngestDate Thu Aug 21 18:20:21 EDT 2025
Fri Jul 11 00:57:33 EDT 2025
Tue Dec 28 13:59:06 EST 2021
Wed Feb 19 02:28:12 EST 2025
Tue Jul 01 00:43:25 EDT 2025
Thu Apr 24 22:51:34 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords epidemiology
infants
central nervous system infections
enterovirus
children
parechovirus
Language English
License Copyright © 2021 American Society for Microbiology.
All Rights Reserved. https://doi.org/10.1128/ASMCopyrightv2
All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a484t-51b7dd94eea0974f0b03cbadee35e489d6e44d300819c12f08e11f6faf80ba93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation Sasidharan A, Banerjee D, Harrison CJ, Selvarangan R. 2021. Emergence of parechovirus A3 as the leading cause of central nervous system infection, surpassing any single enterovirus type, in children in Kansas City, Missouri, USA, from 2007 to 2016. J Clin Microbiol 59:e02935-20. https://doi.org/10.1128/JCM.02935-20.
ORCID 0000-0003-3275-6657
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8316090
PMID 33692140
PQID 2500382514
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8316090
proquest_miscellaneous_2500382514
asm2_journals_10_1128_JCM_02935_20
pubmed_primary_33692140
crossref_primary_10_1128_JCM_02935_20
crossref_citationtrail_10_1128_JCM_02935_20
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210519
PublicationDateYYYYMMDD 2021-05-19
PublicationDate_xml – month: 5
  year: 2021
  text: 20210519
  day: 19
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of clinical microbiology
PublicationTitleAbbrev J Clin Microbiol
PublicationTitleAlternate J Clin Microbiol
PublicationYear 2021
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
Khetsuriani N (e_1_3_2_4_2) 2006; 55
Maguire HC (e_1_3_2_20_2) 1999; 2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
Centers for Disease Control and Prevention (e_1_3_2_10_2) 2010; 59
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
Levorson, RE, Jantausch, BA, Wiedermann, BL, Spiegel, HM, Campos, JM (B33) 2009; 28
de Jong, EP, van den Beuken, MGA, van Elzakker, EPM, Wolthers, KC, Sprij, AJ, Lopriore, E, Walther, FJ, Brus, F (B34) 2018; 37
Felsenstein, S, Yang, S, Eubanks, N, Sobrera, E, Grimm, JP, Aldrovandi, G (B11) 2014; 33
Sharp, J, Harrison, CJ, Puckett, K, Selvaraju, SB, Penaranda, S, Nix, WA, Oberste, MS, Selvarangan, R (B17) 2013; 32
Janes, VA, Minnaar, R, Koen, G, van Eijk, H, Dijkman-de Haan, K, Pajkrt, D, Wolthers, KC, Benschop, KS (B6) 2014; 19
Aizawa, Y, Izumita, R, Saitoh, A (B31) 2017; 23
Kolehmainen, P, Jaaskelainen, A, Blomqvist, S, Kallio-Kokko, H, Nuolivirta, K, Helminen, M, Roivainen, M, Lappalainen, M, Tauriainen, S (B4) 2014; 33
Selvarangan, R, Nzabi, M, Selvaraju, SB, Ketter, P, Carpenter, C, Harrison, CJ (B16) 2011; 30
de Crom, SC, Rossen, JW, van Furth, AM, Obihara, CC (B15) 2016; 175
Ortner, B, Huang, CW, Schmid, D, Mutz, I, Wewalka, G, Allerberger, F, Yang, JY, Huemer, HP (B25) 2009; 81
van der Sanden, S, de Bruin, E, Vennema, H, Swanink, C, Koopmans, M, van der Avoort, H (B5) 2008; 46
Vollbach, S, Muller, A, Drexler, JF, Simon, A, Drosten, C, Eis-Hubinger, AM, Panning, M (B7) 2015; 12
Sasidharan, A, Harrison, CJ, Banerjee, D, Selvarangan, R (B30) 2019; 57
Harvala, H, Robertson, I, Chieochansin, T, McWilliam Leitch, EC, Templeton, K, Simmonds, P (B18) 2009; 199
Nigrovic, LE, Fine, AM, Monuteaux, MC, Shah, SS, Neuman, MI (B1) 2013; 131
Han, TH, Chung, JY, You, SJ, Youn, JL, Shim, GH (B24) 2013; 58
Yamashita, K, Miyamura, K, Yamadera, S, Kato, N, Akatsuka, M, Inouye, S, Yamazaki, S (B26) 1992; 45
Khetsuriani, N, Lamonte-Fowlkes, A, Oberst, S, Pallansch, MA (B3) 2006; 55
Midgley, CM, Jackson, MA, Selvarangan, R, Franklin, P, Holzschuh, EL, Lloyd, J, Scaletta, J, Straily, A, Tubach, S, Willingham, A, Nix, WA, Oberste, MS, Harrison, CJ, Hunt, C, Turabelidze, G, Gerber, SI, Watson, JT (B13) 2017; 7
Maguire, HC, Atkinson, P, Sharland, M, Bendig, J (B19) 1999; 2
Selvaraju, SB, Nix, WA, Oberste, MS, Selvarangan, R (B20) 2013; 51
Verboon-Maciolek, MA, Krediet, TG, Gerards, LJ, de Vries, LS, Groenendaal, F, van Loon, AM (B12) 2008; 27
Lee, BR, Sasidharan, A, Harrison, CJ, Selvarangan, R (B35) 2020; 59
Nix, WA, Maher, K, Pallansch, MA, Oberste, MS (B21) 2010; 48
Nix, WA, Oberste, MS, Pallansch, MA (B22) 2006; 44
Seo, JH, Yeom, JS, Youn, HS, Han, TH, Chung, JY (B23) 2015; 58
Harvala, H, McLeish, N, Kondracka, J, McIntyre, CL, McWilliam Leitch, EC, Templeton, K, Simmonds, P (B14) 2011; 83
Tseng, FC, Huang, HC, Chi, CY, Lin, TL, Liu, CC, Jian, JW, Hsu, LC, Wu, HS, Yang, JY, Chang, YW, Wang, HC, Hsu, YW, Su, IJ, Wang, JR (B27) 2007; 79
Pajkrt, D, Benschop, KS, Westerhuis, B, Molenkamp, R, Spanjerberg, L, Wolthers, KC (B28) 2009; 28
Abedi, GR, Watson, JT, Nix, WA, Oberste, MS, Gerber, SI (B8) 2018; 67
Benschop, KS, Schinkel, J, Minnaar, RP, Pajkrt, D, Spanjerberg, L, Kraakman, HC, Berkhout, B, Zaaijer, HL, Beld, MG, Wolthers, KC (B29) 2006; 42
Walters, B, Penaranda, S, Nix, WA, Oberste, MS, Todd, KM, Katz, BZ, Zheng, X (B32) 2011; 52
Sano, K, Hamada, H, Hirose, S, Sugiura, K, Harada, S, Koizumi, M, Hara, M, Nishijima, H, Taira, M, Ogura, A, Ogawa, T, Takanashi, JI (B10) 2017; 60
(B9) 2010; 59
Abedi, GR, Watson, JT, Pham, H, Nix, WA, Oberste, MS, Gerber, SI (B2) 2015; 64
References_xml – volume: 2
  start-page: 122
  year: 1999
  ident: e_1_3_2_20_2
  article-title: Enterovirus infections in England and Wales: laboratory surveillance data: 1975 to 1994
  publication-title: Commun Dis Public Health
– ident: e_1_3_2_22_2
  doi: 10.1016/j.jcv.2010.04.007
– ident: e_1_3_2_31_2
  doi: 10.1128/JCM.01698-18
– ident: e_1_3_2_23_2
  doi: 10.1128/JCM.00542-06
– ident: e_1_3_2_30_2
  doi: 10.1086/498905
– ident: e_1_3_2_32_2
  doi: 10.1016/j.jiac.2017.04.009
– ident: e_1_3_2_7_2
  doi: 10.2807/1560-7917.es2014.19.46.20964
– ident: e_1_3_2_11_2
  doi: 10.1111/ped.13467
– ident: e_1_3_2_34_2
  doi: 10.1097/INF.0b013e318194596a
– ident: e_1_3_2_26_2
  doi: 10.1002/jmv.21374
– ident: e_1_3_2_5_2
  doi: 10.1097/INF.0000000000000401
– ident: e_1_3_2_35_2
  doi: 10.1097/INF.0000000000001718
– ident: e_1_3_2_36_2
  doi: 10.1128/JCM.02106-20
– ident: e_1_3_2_15_2
  doi: 10.1002/jmv.22023
– ident: e_1_3_2_29_2
  doi: 10.1097/INF.0b013e3181a7ab5f
– ident: e_1_3_2_8_2
  doi: 10.1186/s12985-015-0427-9
– ident: e_1_3_2_12_2
  doi: 10.1097/INF.0000000000000112
– ident: e_1_3_2_6_2
  doi: 10.1128/JCM.00168-08
– ident: e_1_3_2_33_2
  doi: 10.1016/j.jcv.2011.07.008
– ident: e_1_3_2_18_2
  doi: 10.1097/INF.0b013e318276b328
– ident: e_1_3_2_27_2
  doi: 10.7883/yoken1952.45.151
– ident: e_1_3_2_21_2
  doi: 10.1128/JCM.01982-12
– ident: e_1_3_2_17_2
  doi: 10.1097/INF.0b013e3181fbefc8
– ident: e_1_3_2_25_2
  doi: 10.1016/j.jcv.2013.05.023
– ident: e_1_3_2_19_2
  doi: 10.1086/599094
– ident: e_1_3_2_14_2
  doi: 10.1093/jpids/pix010
– volume: 55
  start-page: 1
  year: 2006
  ident: e_1_3_2_4_2
  article-title: Enterovirus surveillance–United States, 1970-2005
  publication-title: MMWR Surveill Summ
– ident: e_1_3_2_24_2
  doi: 10.3345/kjp.2015.58.3.102
– ident: e_1_3_2_3_2
  doi: 10.15585/mmwr.mm6434a3
– ident: e_1_3_2_9_2
  doi: 10.15585/mmwr.mm6718a2
– ident: e_1_3_2_28_2
  doi: 10.1002/jmv.21006
– volume: 59
  start-page: 1577
  year: 2010
  ident: e_1_3_2_10_2
  article-title: Nonpolio enterovirus and human parechovirus surveillance - United States, 2006-2008
  publication-title: MMWR Morb Mortal Wkly Rep
– ident: e_1_3_2_13_2
  doi: 10.1097/INF.0b013e31815c1b07
– ident: e_1_3_2_16_2
  doi: 10.1007/s00431-016-2725-7
– ident: e_1_3_2_2_2
  doi: 10.1542/peds.2012-3077
– volume: 33
  start-page: 1109
  year: 2014
  end-page: 1113
  ident: B4
  article-title: Human parechovirus type 3 and 4 associated with severe infections in young children
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000000401
– volume: 59
  start-page: 1577
  year: 2010
  end-page: 1580
  ident: B9
  article-title: Nonpolio enterovirus and human parechovirus surveillance - United States, 2006-2008
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 2
  start-page: 122
  year: 1999
  end-page: 125
  ident: B19
  article-title: Enterovirus infections in England and Wales: laboratory surveillance data: 1975 to 1994
  publication-title: Commun Dis Public Health
– volume: 59
  year: 2020
  ident: B35
  article-title: Positive impact of routine testing for enterovirus and parechovirus on length of hospitalization and antimicrobial use among inpatients ≤6 months of age
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.02106-20
– volume: 51
  start-page: 452
  year: 2013
  end-page: 458
  ident: B20
  article-title: Optimization of a combined human parechovirus-enterovirus real-time reverse transcription-PCR assay and evaluation of a new parechovirus 3-specific assay for cerebrospinal fluid specimen testing
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01982-12
– volume: 83
  start-page: 889
  year: 2011
  end-page: 896
  ident: B14
  article-title: Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in Edinburgh: HPeV type 3 identified as the most common picornavirus type
  publication-title: J Med Virol
  doi: 10.1002/jmv.22023
– volume: 37
  start-page: 113
  year: 2018
  end-page: 118
  ident: B34
  article-title: Epidemiology of sepsis-like illness in young infants: major role of enterovirus and human parechovirus
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000001718
– volume: 32
  start-page: 213
  year: 2013
  end-page: 216
  ident: B17
  article-title: Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0b013e318276b328
– volume: 48
  start-page: 202
  year: 2010
  end-page: 207
  ident: B21
  article-title: Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2010.04.007
– volume: 55
  start-page: 1
  year: 2006
  end-page: 20
  ident: B3
  article-title: Enterovirus surveillance–United States, 1970-2005
  publication-title: MMWR Surveill Summ
– volume: 81
  start-page: 317
  year: 2009
  end-page: 324
  ident: B25
  article-title: Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes
  publication-title: J Med Virol
  doi: 10.1002/jmv.21374
– volume: 28
  start-page: 1008
  year: 2009
  end-page: 1010
  ident: B28
  article-title: Clinical characteristics of human parechoviruses 4–6 infections in young children
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0b013e3181a7ab5f
– volume: 67
  start-page: 515
  year: 2018
  end-page: 518
  ident: B8
  article-title: Enterovirus and parechovirus surveillance - United States, 2014-2016
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6718a2
– volume: 57
  year: 2019
  ident: B30
  article-title: Emergence of parechovirus A4 central nervous system infections among infants in Kansas City, Missouri, USA
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01698-18
– volume: 64
  start-page: 940
  year: 2015
  end-page: 943
  ident: B2
  article-title: Enterovirus and human parechovirus surveillance - United States, 2009-2013
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6434a3
– volume: 79
  start-page: 1850
  year: 2007
  end-page: 1860
  ident: B27
  article-title: Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data
  publication-title: J Med Virol
  doi: 10.1002/jmv.21006
– volume: 12
  start-page: 199
  year: 2015
  ident: B7
  article-title: Prevalence, type and concentration of human enterovirus and parechovirus in cerebrospinal fluid samples of pediatric patients over a 10-year period: a retrospective study
  publication-title: Virol J
  doi: 10.1186/s12985-015-0427-9
– volume: 23
  start-page: 419
  year: 2017
  end-page: 426
  ident: B31
  article-title: Human parechovirus type 3 infection: an emerging infection in neonates and young infants
  publication-title: J Infect Chemother
  doi: 10.1016/j.jiac.2017.04.009
– volume: 45
  start-page: 151
  year: 1992
  end-page: 161
  ident: B26
  article-title: Enteroviral aseptic meningitis in Japan, 1981-1991. A report of the National Epidemiological Surveillance of Infectious Agents in Japan
  publication-title: Jpn J Med Sci Biol
  doi: 10.7883/yoken1952.45.151
– volume: 27
  start-page: 241
  year: 2008
  end-page: 245
  ident: B12
  article-title: Severe neonatal parechovirus infection and similarity with enterovirus infection
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0b013e31815c1b07
– volume: 7
  start-page: 104
  year: 2017
  end-page: 112
  ident: B13
  article-title: Severe parechovirus 3 infections in young infants-Kansas and Missouri, 2014
  publication-title: J Pediatric Infect Dis Soc
  doi: 10.1093/jpids/pix010
– volume: 30
  start-page: 238
  year: 2011
  end-page: 242
  ident: B16
  article-title: Human parechovirus 3 causing sepsis-like illness in children from midwestern United States
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0b013e3181fbefc8
– volume: 44
  start-page: 2698
  year: 2006
  end-page: 2704
  ident: B22
  article-title: Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00542-06
– volume: 28
  start-page: 545
  year: 2009
  end-page: 547
  ident: B33
  article-title: Human parechovirus-3 infection: emerging pathogen in neonatal sepsis
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0b013e318194596a
– volume: 46
  start-page: 2884
  year: 2008
  end-page: 2889
  ident: B5
  article-title: Prevalence of human parechovirus in the Netherlands in 2000 to 2007
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00168-08
– volume: 199
  start-page: 1753
  year: 2009
  end-page: 1760
  ident: B18
  article-title: Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples
  publication-title: J Infect Dis
  doi: 10.1086/599094
– volume: 60
  start-page: 142
  year: 2017
  end-page: 147
  ident: B10
  article-title: Prevalence and characteristics of human parechovirus and enterovirus infections in febrile infants
  publication-title: Pediatr Int
  doi: 10.1111/ped.13467
– volume: 33
  start-page: e87
  year: 2014
  end-page: e91
  ident: B11
  article-title: Human parechovirus central nervous system infections in southern California children
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000000112
– volume: 175
  start-page: 1023
  year: 2016
  end-page: 1029
  ident: B15
  article-title: Enterovirus and parechovirus infection in children: a brief overview
  publication-title: Eur J Pediatr
  doi: 10.1007/s00431-016-2725-7
– volume: 52
  start-page: 187
  year: 2011
  end-page: 191
  ident: B32
  article-title: Detection of human parechovirus (HPeV)-3 in spinal fluid specimens from pediatric patients in the Chicago area
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2011.07.008
– volume: 58
  start-page: 102
  year: 2015
  end-page: 107
  ident: B23
  article-title: Prevalence of human parechovirus and enterovirus in cerebrospinal fluid samples in children in Jinju, Korea
  publication-title: Korean J Pediatr
  doi: 10.3345/kjp.2015.58.3.102
– volume: 19
  start-page: 20964
  year: 2014
  ident: B6
  article-title: Presence of human non-polio enterovirus and parechovirus genotypes in an Amsterdam hospital in 2007 to 2011 compared to national and international published surveillance data: a comprehensive review
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.es2014.19.46.20964
– volume: 58
  start-page: 194
  year: 2013
  end-page: 199
  ident: B24
  article-title: Human parechovirus-3 infection in children, South Korea
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2013.05.023
– volume: 42
  start-page: 204
  year: 2006
  end-page: 210
  ident: B29
  article-title: Human parechovirus infections in Dutch children and the association between serotype and disease severity
  publication-title: Clin Infect Dis
  doi: 10.1086/498905
– volume: 131
  start-page: 670
  year: 2013
  end-page: 676
  ident: B1
  article-title: Trends in the management of viral meningitis at United States children's hospitals
  publication-title: Pediatrics
  doi: 10.1542/peds.2012-3077
SSID ssj0014455
Score 2.436751
Snippet Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous...
Picornaviruses, including species A to D (EV) and species A (PeV-A), are the leading reported causes of pediatric central nervous system infections in the...
Picornaviruses, including Enterovirus species A to D (EV) and Parechovirus species A (PeV-A), are the leading reported causes of pediatric central nervous...
SourceID pubmedcentral
proquest
asm2
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Epidemiology
Title Emergence of Parechovirus A3 as the Leading Cause of Central Nervous System Infection, Surpassing Any Single Enterovirus Type, in Children in Kansas City, Missouri, USA, from 2007 to 2016
URI https://www.ncbi.nlm.nih.gov/pubmed/33692140
https://journals.asm.org/doi/10.1128/JCM.02935-20
https://www.proquest.com/docview/2500382514
https://pubmed.ncbi.nlm.nih.gov/PMC8316090
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VIhAXBOVVXhoQnBKnu_bGsY9RKFSFICRaKTdrba-Jo9ZBeVSCv8b_4syMd_1ISqXCxVnZ67Xj-XZ2ZnYejL3JlEh04qeOdvuJI0MVODFKyY6boKaNEoccpGW2z8_-0ak8nvQnOzu_W15L61XcS37-Na7kf6iK55CuFCX7D5StB8UT2Eb64hEpjMdr0fjQxk6Wev8XhcxrOr_IF-tlZ-hRARkSKj8ZL_nOSK2N2d7ac5G9LS7I_9XkLEdGYbyyjD0UPz9K1aXJpEDugo0z3SkdCOwDSH-lnhQ0WMWDY_sjVR9fdka21sAYyUpWfmqffh3STxnPQqZLknpRLvCvEI_rkM3zvMkVVduDFH5sSjVtEyDMVNEYFlShFzPjX_QuX03zhskuyoKLWzkVWhtj-uyCxvxm98aotVCztmHEFbSn32K_9Y5X2_11vP3KdlkI8VZhss_0tFkJKNGq7_NJe6mwycvzhu9fXoFciqo4Ho17HCWpvuPyZqWt_R-rSzfYTRfVG6q88WFSuyahjts3lTfsa1UBG25w0B4YpQi1PHc3JapLatK2t29LfDq5x-5awsLQgPg-29HFHrtlKqH-2GO3x9bH4wH7VaMa5hm0UQ1DD9QSENVgUQ0lqqmfRTVYVINBNdSo7kKDaUBMg8E0tDANhOku5AVUiKa2QTQQortQ4bkLiOYuEJaBsAyrORCWH7KT94cnoyPHlhhxlAzkyumLeJCmodRacdSsMx5zL4lVqrXX1zIIU19LmXql4JwIN-OBFiLzM5UFPFah94jtFvNCP2Gg40ykvogTXwcylKini4EWA2SEqGBxnu2z10SsyLKPZVRq324QIUWjkqKRy_dZpyJllNgc_VQq5uyK3m_r3t9Nbpor-r2qUBHh4kE7gjgTkRYR6j_co-B1uc8eG5TUI3meH7pC4t2DDfzUHSgx_eaVIp-WCeoDT_g85E-v85efsTvN5H3OdleLtX6Bcv4qfllOij9lXP76
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Emergence+of+Parechovirus+A3+as+the+Leading+Cause+of+Central+Nervous+System+Infection%2C+Surpassing+Any+Single+Enterovirus+Type%2C+in+Children+in+Kansas+City%2C+Missouri%2C+USA%2C+from+2007+to+2016&rft.jtitle=Journal+of+clinical+microbiology&rft.au=Sasidharan%2C+Anjana&rft.au=Banerjee%2C+Dithi&rft.au=Harrison%2C+Christopher+J&rft.au=Selvarangan%2C+Rangaraj&rft.date=2021-05-19&rft.pub=American+Society+for+Microbiology&rft.issn=0095-1137&rft.eissn=1098-660X&rft.volume=59&rft.issue=6&rft_id=info:doi/10.1128%2FJCM.02935-20&rft.externalDocID=02935-20
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-1137&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-1137&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-1137&client=summon